Is it ethical to use drospirenone-containing combined oral contraceptives?
Pittrof, R.
journal of family planning and reproductive health care 38(3): 205-6; author reply 206-7
2012
ISSN/ISBN: 1471-1893 PMID: 22787258 DOI: 10.1136/jfprhc-2012-100344Document Number: 552668
Document emailed within 0-6 h
Related Documents
Pittrof, R. 2012: Is it ethical to use drospirenone-containing combined oral contraceptives? journal of family planning and reproductive health care 38(3): 205-6; author reply 206-7Marr, J.; Gerlinger, C.; Kunz, M. 2012: A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen European Journal of Obstetrics Gynecology and Reproductive Biology 162(1): 91-95
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Van Vloten, W.A.; van Haselen, C.W.; van Zuuren, E.J.; Gerlinger, C.; Heithecker, R. 2002: The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea Cutis 69(4 Suppl): 2-15
Wichianpitaya, J.; Taneepanichskul, S. 2013: A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms Obstetrics and Gynecology International 2013: 487143
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Macut, D.; Božić Antić, I.; Nestorov, J.; Topalović, V.; Bjekić Macut, J.; Panidis, D.; Kastratović Kotlica, B.; Papadakis, E.; Matić, G.; Vojnović Milutinović, D. 2015: The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome Hormones 14(1): 109-117
Jick, S.S.; Hernandez, R.K. 2011: Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Bmj 342: D2151
Nappi, R.E.; Albani, F.; Tonani, S.; Santamaria, V.; Pisani, C.; Terreno, E.; Martini, E.; Polatti, F. 2009: Psychosexual well-being in women using oral contraceptives containing drospirenone Functional Neurology 24(2): 71-75
Lopez, L.M.; Kaptein, A.A.; Helmerhorst, F.M. 2009: Oral contraceptives containing drospirenone for premenstrual syndrome Cochrane Database of Systematic Reviews 2: Cd006586
Brown, D.A.; Vartan, C.M. 2011: Risk of venous thromboembolism with drospirenone-containing oral contraceptives American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(11): 1003-1010
Tchaikovski, S.N.; Thomassen, M.C.L.G.D.; Costa, S.D.; Bremme, K.; Rosing, J. 2014: Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives Thrombosis Research 134(5): 1032-1037
Loughlin, J.; Seeger, J.D.; Eng, P.M.; Foegh, M.; Clifford, C.R.; Cutone, J.; Walker, A.M. 2008: Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives Contraception 78(5): 377-383
Karabay, C.Y.; Kocabay, G.; Oduncu, V.; Kalayci, A.; Guler, A.; Karagöz, A.; Candan, O.; Basaran, O.; Zehir, R.; Izgi, A.ın.; Esen, A.M.; Kırma, C. 2013: Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 82(3): 387-393
Stuart, G.S.; Moses, A.; Corbett, A.; Phiri, G.; Kumwenda, W.; Mkandawire, N.; Chintedze, J.; Malunga, G.; Hosseinipour, M.; Cohen, M.S.; Stanczyk, F.Z.; Kashuba, A.D.M. 2011: Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi Journal of Acquired Immune Deficiency Syndromes 58(2): E40-E43
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292